1-3 of 3
Guowei Li
Close
Save search
Sort by
Journal Articles

Azacitidine, Homoharringtonine and Cytarabine Combined with Granulocyte Colony-Stimulating Factor As Frontline Treatment for Older Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase III Study in China

Free
Yafang Ma, Xiang Zhang, Jian Hou, Lijing Shen, Fei Li, Fancong Kong, Ying Lu, Guowei Li, Jie Jin, Wenjuan Yu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4280.
https://doi.org/10.1182/blood-2024-203359
Published: 2024
Journal Articles

Flumatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: An Open-Label, Multi-Center Study

Free
Ziyu Wen, Ying Zhao, Guowei Li, YongZhong Su, FeiHeng Chen, HongFang Tao, ZhengJin Zheng, Wuqiang Lin, XiuLi Chen, Meili Meng, Lian Yu, LongTian Chen, JianQing Huang, Guocai Wu, Mengxia Zhao, Zhenfang Liu, Hongqian Zhu, Yirong Jiang, Qifa Liu, Xiaoli Liu, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3175.
https://doi.org/10.1182/blood-2023-181456
Published: 2023
Journal Articles

Frontline Treatment with Zanubrutinib Plus Rituximab (ZR) Followed By Short Course R-Dhaox Shows Potent Efficacy in Patients with Mantle Cell Lymphoma (MCL) - Preliminary Results of Phase II CHESS Clinical Trial

Free
Qingqing Cai, Yi Xia, Panpan Liu, Yuchen Zhang, Huiqiang Huang, Yan Gao, Guowei Li, Xiuhua Sun, Xueyi Pan
Journal: Blood
Blood (2022) 140 (Supplement 1): 9356–9357.
https://doi.org/10.1182/blood-2022-166237
Published: 2022